Novel Microdevices’ Post

📢 Exciting News for Novel Microdevices! We’re thrilled to announce that Novel Microdevices has secured an additional $2.7 million in follow-on funding from the The National Institutes of Health RADx Tech program, building on the success of our next-gen point-of-care diagnostic platform! 🎉 This funding milestone reflects the hard work of our dedicated team and our commitment to delivering groundbreaking, lab-quality diagnostics that bring timely, reliable results directly to clinical settings. Our high-performance RT-PCR platform provides results in just 15 minutes, testing for RSV, Flu A/B, and COVID-19—empowering clinicians and patients like never before. A big thank you to NIH RADx Tech for their support in accelerating our mission to revolutionize diagnostic testing. This follow-on funding moves us closer to our goal of making high-quality diagnostics accessible at the point of care, transforming healthcare for the better. Here’s to more milestones ahead! 🚀 Read more about this exciting development: https://lnkd.in/em9uwPhY #HealthcareInnovation #Diagnostics #PointOfCare #Funding #NIH #RADxTech #NovelMicrodevices #respiratoryhealth #infectiousdiseases #maryland #smallbusiness #Baltimore #CityGarage

To view or add a comment, sign in

Explore topics